Aug 8, 2024 05:51PM
Nov 29, 2023 07:30AM
Oct 19, 2023 07:30AM
Oct 19, 2023 07:30AM
Apr 26, 2023 08:30AM
Apr 26, 2023 08:30AM
Apr 18, 2023 08:32AM SAB Biotherapeutics (SABS) Granted FDA Breakthrough Therapy Designation for SAB-176
Apr 18, 2023 08:30AM
Apr 13, 2023 08:31AM
Apr 13, 2023 08:30AM
Jan 10, 2023 08:00AM
Nov 21, 2022 08:14AM
Aug 9, 2022 04:30PM
Mar 2, 2022 06:00AM SAB Biotherapeutics (SABS) Announces NIH is Discontinuing Phase 3 ACTIV-2 Trial Assessing SAB-185 for Treatment of COVID-19 Due to Declining COVID Hospitalizations
Mar 2, 2022 06:00AM
Mar 2, 2022 05:53AM
Mar 1, 2022 07:30PM
Jan 24, 2022 06:00AM
Dec 16, 2021 06:01AM
Dec 16, 2021 06:00AM
Oct 25, 2021 07:39AM SAB Biotherapeutics Debuts as Publicly Traded Next-Generation Immunotherapy Company

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All